Tag : BI News

Digital Transformation in Energy & Decarbonization

Dragonfly Energy Launches Battle Born Solar Panels

GlobeNewswire
High-efficiency solar panels built to deliver more power, optimized with next-generation anti-shading technology Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry...
Stakeholder Engagement, ESG, & Policy Advocacy

CenterPoint Energy Expands Workforce for Winter Weather Prep

PR Newswire
Approximately 3,300 CenterPoint employees and contract workers supporting storm preparation and potential restoration efforts across Houston and parts of Southeast Texas Emergency Operations Center fully...
Workforce Development & the Future of Energy

System One Names Brian Anderson EVP of Energy & Utilities

PR Newswire
System One, a leading provider of specialized, highly technical outsourced services and workforce solutions, announced today the appointment of Brian Anderson as Executive Vice President...
Digital Transformation in Energy & Decarbonization

HiTHIUM Becomes World’s First Lighthouse Factory for Energy Storage

PR Newswire
The World Economic Forum (WEF) recently announced the latest members of its Global Lighthouse Networks 2026, with HiTHIUM’s Chongqing manufacturing base successfully selected. The factory becomes...
Clinical Research, Pharma & Healthcare Financing

Syremis Therapeutics Raises $165M for Mental Health Drugs

Business Wire
Addressing major unmet needs in mental health with pharmacology rooted in emerging and clinically validated neuropsychiatric biology Lead program ST-905, a potent M1/M4 muscarinic agonist,...
Healthcare Infrastructure, Operations & Supply Chain

AtomVie Secures Supply Deal with Ionetix for Ac-225 Drugs

PR Newswire
AtomVie Global Radiopharma (AtomVie), a global radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) specializing in GMP manufacturing and clinical supply, is pleased to announce a...
Clinical Research, Pharma & Healthcare Financing

PharmAla Biotech Contracts UK CDMO for ALA-002 Production

GlobeNewswire
PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class...